Literature DB >> 10409712

A 36-residue peptide contains all of the information required for 7B2-mediated activation of prohormone convertase 2.

L Muller1, P Zhu, M A Juliano, L Juliano, I Lindberg.   

Abstract

The prohormone convertases (PCs) are serine proteinases responsible for the processing of secretory protein precursors. PC2 is the only member of this family whose activation requires intracellular interaction with a helper protein, the neuroendocrine protein 7B2. In order to gain a better understanding of the mechanism of proPC2 activation, we have characterized the structural determinants of 7B2 required for proPC2 activation. We had already identified a proline-rich binding determinant in the 21-kDa domain, the portion of 7B2 responsible for proPC2 activation. We have now investigated the function of the weakly conserved amino-terminal portion of 21-kDa 7B2 by sequential deletions. Mutant proteins were analyzed in four assays: binding to proPC2, facilitation of proPC2 maturation, and activation of proPC2 in vivo and in vitro. We found that the amino-terminal half of 7B2 is not involved in proPC2 activation, and we identified an active 36-residue peptide that contains the previously characterized proline-rich sequence as well as an alpha-helix and the only disulfide bond of 7B2. Mutation of the alpha-helix and of the cysteines demonstrated that these determinants are absolutely required for PC2 activation. Thus, the 186-residue full-length 7B2 rat protein can be functionally reduced to an internal segment of only 36 residues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10409712     DOI: 10.1074/jbc.274.30.21471

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Neuroendocrine secretory protein 7B2: structure, expression and functions.

Authors:  M Mbikay; N G Seidah; M Chrétien
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

Review 2.  Proteases for processing proneuropeptides into peptide neurotransmitters and hormones.

Authors:  Vivian Hook; Lydiane Funkelstein; Douglas Lu; Steven Bark; Jill Wegrzyn; Shin-Rong Hwang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

3.  7B2 prevents unfolding and aggregation of prohormone convertase 2.

Authors:  Sang-Nam Lee; Iris Lindberg
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

Review 4.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

5.  Phosphorylation and Alternative Splicing of 7B2 Reduce Prohormone Convertase 2 Activation.

Authors:  Bruno Ramos-Molina; Iris Lindberg
Journal:  Mol Endocrinol       Date:  2015-03-26

6.  Modulation of prohormone convertase 1/3 properties using site-directed mutagenesis.

Authors:  Akihiko Ozawa; Juan R Peinado; Iris Lindberg
Journal:  Endocrinology       Date:  2010-07-07       Impact factor: 4.736

7.  Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS.

Authors:  Juan R Peinado; Furqan Sami; Nina Rajpurohit; Iris Lindberg
Journal:  FEBS Lett       Date:  2013-09-13       Impact factor: 4.124

8.  Cell-surface processing of the metalloprotease pro-ADAMTS9 is influenced by the chaperone GRP94/gp96.

Authors:  Bon-Hun Koo; Suneel S Apte
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

9.  Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2.

Authors:  Liora S Katz; Yvan Gosmain; Eric Marthinet; Jacques Philippe
Journal:  Mol Cell Biol       Date:  2009-02-17       Impact factor: 4.272

10.  Identification of proSAAS homologs in lower vertebrates: conservation of hydrophobic helices and convertase-inhibiting sequences.

Authors:  H Kudo; J Liu; E J R Jansen; A Ozawa; P Panula; G J M Martens; I Lindberg
Journal:  Endocrinology       Date:  2008-10-23       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.